CRMD | CorMedix Inc. to Report Third Quarter 2020 Financial Results and Provide a Corporate Update on November 5

BERKELEY HEIGHTS, N.J., Oct.29, 2020 (GLOBE NEWSWIRE) — CorMedix Inc.(NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it will report its financial results for the third quarter ended September 30, 2020, after the market close on Thursday,Wallstreet:Online